ENTERA BIO LTD

ENTX · NASDAQ

Updated at 2026-10-17 21:47:31

$2.68-3.24%
Today's High
$2.75
Today’s Low
$2.62
ENTERA BIO LTD (ENTX) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$2.72
Previous Close
$2.68
Volume
572.89K
Market Cap
$466.11M
P/E Ratio
--
EPS
$-0.35

Previous Day Range

$2.62$2.75

52-Week Range

$0.91$4.20

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
KIRYAT HADASSAH MINRAV BUILDING, JERUSALEM, ISRAEL, 9112002
Country
IL
Listing Date
2018-06-28
Fiscal Year End
December
Shares Outstanding
172.25M
CIK
0001638097

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally administered large molecule therapies for unmet medical needs. The company is headquartered in Jerusalem, Israel.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

$0

2025-09-30

$0

Operating Expenses

2026-06-30

$4.56M

2026-03-31

$3.53M

2025-12-31

$3.04M

2025-09-30

$3.24M

Net Income

2026-06-30

-$7.31M

2026-03-31

-$3.5M

2025-12-31

-$3.01M

2025-09-30

-$3.2M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

Earnings Per Share

2026-06-30

$-0.14

2026-03-31

$-0.07

2025-12-31

$-0.06

2025-09-30

$-0.07

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$4.55M

2026-03-31

-$3.49M

2025-12-31

-$3M

2025-09-30

-$3.19M

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.